Francesco Saverio Ragusa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Francesco Saverio Ragusa has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Nicola Veronese
Unit of Geriatrics, Department of Internal Medicine and Geriatrics, University of Palermo, Palermo, Italy
9 shared publications - Mario Barbagallo
Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, 90100 Palermo, Italy
7 shared publications Mario Barbagallo
Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties, “G. D’Alessandro”-PROMISE-University of Palermo, Palermo, Italy
6 shared publications- Ligia Juliana Dominguez
Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, 90100 Palermo, Italy
5 shared publications Nicola Veronese
Saint Camillus International, University of Health Sciences, Rome, Italy
5 shared publications- Alessandro D'ALeo
Geriatric Unit, Department of Internal Medicine and Geriatrics, University of Palermo, 90127 Palermo, Italy
4 shared publications
Latest Publications
- Open Access
- 3 August 2026
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 38 (1)
The prognostic value of frailty criteria in older adults: a systematic review and meta-analysis
Introduction: Frailty, a prevalent geriatric syndrome, increases susceptibility to adverse outcomes like mortality, cardiovascular disease, and hospitalization. This study evaluated the Fried frailty phenotype and its components’ association with clinical outcomes, focusing on mortality. Methods: We conducted a systematic review and meta-analysis of studies on individuals aged 50 or more from databases searched up to October 2024. Included studies assessed at least one frailty criterion (weakness, slowness, exhaustion, physical inactivity, weight loss) and reported hazard ratios (HRs) for mortality or other outcomes. Random-effects models and subgroup analyses (e.g., heart failure, chronic kidney disease) were employed. Results: From 3445 articles, 36 studies were included. All frailty components are significantly associated with all-cause mortality: weakness (HR: 1.44, 95%CI: 1.30–1.59, p < 0.01), slowness (HR: 1.75, 95%CI: 1.56–1.95, p < 0.01), exhaustion (HR: 1.47, 95%CI: 1.29–1.68, p < 0.01), physical inactivity (HR: 1.72, 95%CI: 1.55–1.92, p < 0.01), and weight loss (HR: 1.56, 95%CI: 1.31–1.84, p < 0.01). Slowness, weakness, and physical inactivity were linked to cardiovascular mortality (HRs: 1.97, 1.45, 1.26, respectively, p < 0.01), while slowness and exhaustion were also linked to an increased risk of hospitalization (HRs: 1.46, 1.25, p < 0.01). Slowness was associated with a two-fold higher mortality risk (I2 = 57%, HR: 1.99, 95%CI: 1.73–2.30, p < 0.01). Subgroup analyses confirmed these links in heart failure and chronic kidney disease patients. Conclusion: Frailty components, especially weakness and slowness, are significantly associated with mortality and related outcomes, highlighting the urgency of early frailty detection to improve patient prognosis. Graphical This systematic review and meta-analysis of 36 studies demonstrates that the components of frailty, when considered individually, are significantly associated with an increased mortality risk; weakness (HR: 1.44), slowness (HR: 1.75), exhaustion (HR: 1.47), physical inactivity (HR: 1.72), and unintentional weight loss (HR: 1.56). Slowness and weakness are also associated with cardiovascular mortality and hospitalization, with slowness associated with a two-fold higher mortality risk in community-dwelling older adults (HR: 1.99). These robust associations, confirmed in heart failure and chronic kidney disease subgroups, highlight frailty's critical role in adverse outcomes, urging early identification and intervention to enhance patient care and reduce clinical burden.
- 3 August 2026
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 38 (1)
Open AccessThe prognostic value of frailty criteria in older adults: a systematic review and meta-analysis
Introduction: Frailty, a prevalent geriatric syndrome, increases susceptibility to adverse outcomes like mortality, cardiovascular disease, and hospitalization. This study evaluated the Fried frailty phenotype and its components’ association with clinical outcomes, focusing on mortality. Methods: We conducted a systematic review and meta-analysis of studies on individuals aged 50 or more from databases searched up to October 2024. Included studies assessed at least one frailty criterion (weakness, slowness, exhaustion, physical inactivity, weight loss) and reported hazard ratios (HRs) for mortality or other outcomes. Random-effects models and subgroup analyses (e.g., heart failure, chronic kidney disease) were employed. Results: From 3445 articles, 36 studies were included. All frailty components are significantly associated with all-cause mortality: weakness (HR: 1.44, 95%CI: 1.30–1.59, p < 0.01), slowness (HR: 1.75, 95%CI: 1.56–1.95, p < 0.01), exhaustion (HR: 1.47, 95%CI: 1.29–1.68, p < 0.01), physical inactivity (HR: 1.72, 95%CI: 1.55–1.92, p < 0.01), and weight loss (HR: 1.56, 95%CI: 1.31–1.84, p < 0.01). Slowness, weakness, and physical inactivity were linked to cardiovascular mortality (HRs: 1.97, 1.45, 1.26, respectively, p < 0.01), while slowness and exhaustion were also linked to an increased risk of hospitalization (HRs: 1.46, 1.25, p < 0.01). Slowness was associated with a two-fold higher mortality risk (I2 = 57%, HR: 1.99, 95%CI: 1.73–2.30, p < 0.01). Subgroup analyses confirmed these links in heart failure and chronic kidney disease patients. Conclusion: Frailty components, especially weakness and slowness, are significantly associated with mortality and related outcomes, highlighting the urgency of early frailty detection to improve patient prognosis. Graphical This systematic review and meta-analysis of 36 studies demonstrates that the components of frailty, when considered individually, are significantly associated with an increased mortality risk; weakness (HR: 1.44), slowness (HR: 1.75), exhaustion (HR: 1.47), physical inactivity (HR: 1.72), and unintentional weight loss (HR: 1.56). Slowness and weakness are also associated with cardiovascular mortality and hospitalization, with slowness associated with a two-fold higher mortality risk in community-dwelling older adults (HR: 1.99). These robust associations, confirmed in heart failure and chronic kidney disease subgroups, highlight frailty's critical role in adverse outcomes, urging early identification and intervention to enhance patient care and reduce clinical burden.
- Open Access
- 21 July 2026
- Published by MDPI AG in Geriatrics
- Vol. 11 (4) , 92
Muscle Matters: Dietary Supplement Use and Sarcopenia Risk
Background: The association between dietary supplement use and risk of sarcopenia in older adults remains poorly investigated. The primary objective of this study was to investigate the association between risk of sarcopenia and supplement use in older adults. Methods: A cross-sectional study was conducted to analyze the association between supplement use and risk of sarcopenia, assessed by the SARC-F questionnaire, in older outpatients. The associations between risk of sarcopenia and dietary supplement use were examined through logistic regression models. Results: A total of 162 participants were included in this study. Among supplement users (92 patients), 55.4% were identified as being at risk of sarcopenia (SARC-F ≥ 4). Regarding SARC-F components, dietary supplement users exhibited significantly higher median scores for walking assistance (median 1 vs. 0, p = 0.004) and rising from a chair (median 1 vs. 0, p = 0.04) compared to non-users. Individuals at risk were significantly more likely to use dietary supplements compared with those not at risk (OR 1.98, 95% CI 1. 05–3.76; p = 0.034), and this association remained significant after adjustment for confounders, such as sex, age, study, and marital status (OR 2.35, 95% CI 1.21–4.72; p = 0.013). Cognitive decline was the most frequently reported reason for supplement use in both groups. Conclusions: Dietary supplement use is highly prevalent among older adults and independently associated with sarcopenia risk, particularly tracking with functional limitations. Rather than a causal factor, supplementation may serve as a surrogate indicator of overall clinical vulnerability. These findings underscore the importance of assessing muscle health in older supplement users.
- 21 July 2026
- Published by MDPI AG in Geriatrics
- Vol. 11 (4) , 92
Open AccessMuscle Matters: Dietary Supplement Use and Sarcopenia Risk
Background: The association between dietary supplement use and risk of sarcopenia in older adults remains poorly investigated. The primary objective of this study was to investigate the association between risk of sarcopenia and supplement use in older adults. Methods: A cross-sectional study was conducted to analyze the association between supplement use and risk of sarcopenia, assessed by the SARC-F questionnaire, in older outpatients. The associations between risk of sarcopenia and dietary supplement use were examined through logistic regression models. Results: A total of 162 participants were included in this study. Among supplement users (92 patients), 55.4% were identified as being at risk of sarcopenia (SARC-F ≥ 4). Regarding SARC-F components, dietary supplement users exhibited significantly higher median scores for walking assistance (median 1 vs. 0, p = 0.004) and rising from a chair (median 1 vs. 0, p = 0.04) compared to non-users. Individuals at risk were significantly more likely to use dietary supplements compared with those not at risk (OR 1.98, 95% CI 1. 05–3.76; p = 0.034), and this association remained significant after adjustment for confounders, such as sex, age, study, and marital status (OR 2.35, 95% CI 1.21–4.72; p = 0.013). Cognitive decline was the most frequently reported reason for supplement use in both groups. Conclusions: Dietary supplement use is highly prevalent among older adults and independently associated with sarcopenia risk, particularly tracking with functional limitations. Rather than a causal factor, supplementation may serve as a surrogate indicator of overall clinical vulnerability. These findings underscore the importance of assessing muscle health in older supplement users.
- Open Access
- 27 May 2026
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 25, 690-724
Prevention of cognitive decline and dementia: Current evidence on lifestyle factors and dietary patterns
Cognitive decline and dementia represent major and growing global health challenges, driven largely by population aging and increased longevity. Currently, more than 55 million people worldwide live with dementia, a figure projected to rise to approximately 153 million by 2050. Alzheimer’s disease accounts for the majority of cases, and despite extensive research, effective disease-modifying therapies remain limited. Consequently, increasing attention has shifted toward prevention strategies targeting modifiable risk factors. Accumulating evidence indicates that dementia is not an inevitable consequence of aging and that up to 45 % of cases may be attributable to potentially modifiable lifestyle and environmental factors operating across the life course. Lifestyle behaviors—including diet, physical activity, smoking, alcohol consumption, sleep, and social and cognitive engagement—have emerged as key targets for intervention. In particular, adherence to healthy dietary patterns such as the Mediterranean, DASH, and MIND diets has been associated with better cognitive outcomes, while unhealthy dietary patterns may increase risk. However, findings across studies remain heterogeneous, and uncertainties persist regarding causality, optimal exposure timing, and specific lifestyle components. Recent large prospective cohorts, meta-analyses, umbrella reviews, and multidomain intervention trials have advanced understanding of these associations but have also highlighted important gaps, including limited randomized evidence and underrepresentation of diverse populations. This narrative review critically synthesizes current evidence on lifestyle factors and dietary patterns associated with cognitive decline and dementia risk, focusing on recent high-quality studies. By integrating findings across domains, it aims to clarify areas of consensus and uncertainty, inform prevention strategies, and identify priorities for future research and public health action.
- 27 May 2026
- Published by Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V. in EXCLI Journal
- Vol. 25, 690-724
Open AccessPrevention of cognitive decline and dementia: Current evidence on lifestyle factors and dietary patterns
Cognitive decline and dementia represent major and growing global health challenges, driven largely by population aging and increased longevity. Currently, more than 55 million people worldwide live with dementia, a figure projected to rise to approximately 153 million by 2050. Alzheimer’s disease accounts for the majority of cases, and despite extensive research, effective disease-modifying therapies remain limited. Consequently, increasing attention has shifted toward prevention strategies targeting modifiable risk factors. Accumulating evidence indicates that dementia is not an inevitable consequence of aging and that up to 45 % of cases may be attributable to potentially modifiable lifestyle and environmental factors operating across the life course. Lifestyle behaviors—including diet, physical activity, smoking, alcohol consumption, sleep, and social and cognitive engagement—have emerged as key targets for intervention. In particular, adherence to healthy dietary patterns such as the Mediterranean, DASH, and MIND diets has been associated with better cognitive outcomes, while unhealthy dietary patterns may increase risk. However, findings across studies remain heterogeneous, and uncertainties persist regarding causality, optimal exposure timing, and specific lifestyle components. Recent large prospective cohorts, meta-analyses, umbrella reviews, and multidomain intervention trials have advanced understanding of these associations but have also highlighted important gaps, including limited randomized evidence and underrepresentation of diverse populations. This narrative review critically synthesizes current evidence on lifestyle factors and dietary patterns associated with cognitive decline and dementia risk, focusing on recent high-quality studies. By integrating findings across domains, it aims to clarify areas of consensus and uncertainty, inform prevention strategies, and identify priorities for future research and public health action.
- Open Access
- 14 May 2026
- Published by Springer Nature in Health Economics Review
- Vol. 16 (1)
Cost effectiveness of comprehensive geriatric assessment: a systematic review
The role of Comprehensive Geriatric Assessment (CGA) is crucial from a clinical point of view for frail older patients, permitting tailored interventions t
- 14 May 2026
- Published by Springer Nature in Health Economics Review
- Vol. 16 (1)
Open AccessCost effectiveness of comprehensive geriatric assessment: a systematic review
The role of Comprehensive Geriatric Assessment (CGA) is crucial from a clinical point of view for frail older patients, permitting tailored interventions t
- Open Access
Polypharmacy and Dynapenia in Older Adults Undergoing Rehabilitation After Fracture or Elective Orthopedic Surgery
Background and Objectives: Polypharmacy is common among older adults and its impact on the onset of dynapenia, reduced muscle strength and function, is largely unknown. Older adults hospitalized for either post-fracture or elective orthopedic surgery (knee, femur, or hip) and undergoing rehabilitation were included to investigate the association between polypharmacy and dynapenia. A further aim is to investigate associations between polypharmacy and dynapenia with outcomes including mortality, falls, and hospitalizations. Materials and Methods: On the fifth day following surgery, medical doctors administered a structured questionnaire along with physical and instrumental assessments. Polypharmacy was defined as the concurrent and regular use of 5 or more medications, dynapenia was assessed by measuring handgrip strength. The association between dynapenia and polypharmacy was detected with logistic regression, and their impact on adverse outcomes was assessed using Cox models, Kaplan–Meier curves and log-rank tests. Results: A total of 205 older adults (mean age 77.5 years; 79.5% women) were enrolled. After adjusting for sex, age, and the presence of multidimensional frailty, dynapenia was significantly associated with increased adverse outcomes such as mortality, falls, and hospitalizations (HR 2.96, 95% CI 1.22–7.20, p = 0.016). Similarly, polypharmacy was independently linked to a higher risk of mortality, falls and hospitalizations (HR 2.23, 95% CI 1.24–4.10, p = 0.007). At 6 months follow-up, polypharmacy showed a strong and significant association with dynapenia (adjusted OR 2.63, 95% CI 1.21–4.63, p = 0.019). Conclusions: These findings suggest that polypharmacy is strongly associated with dynapenia, both conditions are associated with adverse clinical outcomes in older hospitalized patients. Close monitoring and tailored interventions are recommended to mitigate these risks and improve rehabilitation outcomes in this vulnerable population.
Open AccessPolypharmacy and Dynapenia in Older Adults Undergoing Rehabilitation After Fracture or Elective Orthopedic Surgery
Background and Objectives: Polypharmacy is common among older adults and its impact on the onset of dynapenia, reduced muscle strength and function, is largely unknown. Older adults hospitalized for either post-fracture or elective orthopedic surgery (knee, femur, or hip) and undergoing rehabilitation were included to investigate the association between polypharmacy and dynapenia. A further aim is to investigate associations between polypharmacy and dynapenia with outcomes including mortality, falls, and hospitalizations. Materials and Methods: On the fifth day following surgery, medical doctors administered a structured questionnaire along with physical and instrumental assessments. Polypharmacy was defined as the concurrent and regular use of 5 or more medications, dynapenia was assessed by measuring handgrip strength. The association between dynapenia and polypharmacy was detected with logistic regression, and their impact on adverse outcomes was assessed using Cox models, Kaplan–Meier curves and log-rank tests. Results: A total of 205 older adults (mean age 77.5 years; 79.5% women) were enrolled. After adjusting for sex, age, and the presence of multidimensional frailty, dynapenia was significantly associated with increased adverse outcomes such as mortality, falls, and hospitalizations (HR 2.96, 95% CI 1.22–7.20, p = 0.016). Similarly, polypharmacy was independently linked to a higher risk of mortality, falls and hospitalizations (HR 2.23, 95% CI 1.24–4.10, p = 0.007). At 6 months follow-up, polypharmacy showed a strong and significant association with dynapenia (adjusted OR 2.63, 95% CI 1.21–4.63, p = 0.019). Conclusions: These findings suggest that polypharmacy is strongly associated with dynapenia, both conditions are associated with adverse clinical outcomes in older hospitalized patients. Close monitoring and tailored interventions are recommended to mitigate these risks and improve rehabilitation outcomes in this vulnerable population.
- Open Access
Revolving Door in Older Patients: An Observational Study of Risk Assessment of Rehospitalization Using the BRASS Scale
Introduction: The “revolving” door is a phenomenon that refers to the rehospitalization of older patients who, after being discharged, soon require specialized hospital care again. Unfortunately, the use of tools able to predict this phenomenon is still limited. The aim of this study was to highlight the validity of the Blaylock Risk Assessment Screening (BRASS) Scale in objectively assessing the risk of rehospitalization and mortality among older patients. Methods: Patients were classified as low, medium, or high risk using the BRASS scale. Adverse events (rehospitalization or death) were recorded at baseline and at 12 months. Kaplan–Meier curves evaluated survival and rehospitalization across risk groups, and ROC analysis assessed the BRASS Scale’s predictive value for mortality. Results: Out of 179 enrolled older adults (mean age 67.7 years), 54.2% were classified as low risk, 29.5% as medium, and 16.8% as high risk based on the BRASS Scale. High-risk patients had significantly higher mortality (HR: 4.40; 95% CI: 1.60–12.19, p = 0.004) and lower survival rates, while intermediate-risk patients had increased rehospitalization (HR: 2.11; 95% CI: 1.09–4.08, p = 0.02). The BRASS scale showed good predictive value for mortality (AUC 0.76). Conclusion: The BRASS Scale has a good predictive value for negative outcomes, and it confirms that a substantial proportion of older patients are at risk of future hospital readmissions and complex discharges. These findings underscore the importance of early post-discharge care planning and the implementation of protected discharge programs.
Open AccessRevolving Door in Older Patients: An Observational Study of Risk Assessment of Rehospitalization Using the BRASS Scale
Introduction: The “revolving” door is a phenomenon that refers to the rehospitalization of older patients who, after being discharged, soon require specialized hospital care again. Unfortunately, the use of tools able to predict this phenomenon is still limited. The aim of this study was to highlight the validity of the Blaylock Risk Assessment Screening (BRASS) Scale in objectively assessing the risk of rehospitalization and mortality among older patients. Methods: Patients were classified as low, medium, or high risk using the BRASS scale. Adverse events (rehospitalization or death) were recorded at baseline and at 12 months. Kaplan–Meier curves evaluated survival and rehospitalization across risk groups, and ROC analysis assessed the BRASS Scale’s predictive value for mortality. Results: Out of 179 enrolled older adults (mean age 67.7 years), 54.2% were classified as low risk, 29.5% as medium, and 16.8% as high risk based on the BRASS Scale. High-risk patients had significantly higher mortality (HR: 4.40; 95% CI: 1.60–12.19, p = 0.004) and lower survival rates, while intermediate-risk patients had increased rehospitalization (HR: 2.11; 95% CI: 1.09–4.08, p = 0.02). The BRASS scale showed good predictive value for mortality (AUC 0.76). Conclusion: The BRASS Scale has a good predictive value for negative outcomes, and it confirms that a substantial proportion of older patients are at risk of future hospital readmissions and complex discharges. These findings underscore the importance of early post-discharge care planning and the implementation of protected discharge programs.
- Open Access
- 26 August 2025
- Published by PAGEPress Publications in European Journal of Translational Myology
- Vol. 35 (3)
Observational study for multidimensional assessment in elderly patients hospitalized for post-fracture or elective surgery and functional rehabilitation
Fracture-related hospitalizations are frequent in older adults, with recovery often extended. This study evaluated the prognostic utility of the Multidimensional Prognostic Index (MPI), Handgrip Strength (HGS), Short Physical Performance Battery (SPPB), and Geriatric Depression Scale (GDS) in predicting adverse outcomes—hospitalizations, falls, or mortality—after femoral fracture or total knee arthroplasty surgery. The methods adopted were MPI assessed frailty, SPPB measured physical performance, GDS identified depression, and HGS evaluated muscle strength. Receiver Operating Characteristic (ROC) curves determined their predictive value for adverse outcomes. The study included 206 older adults (mean age 77.5, 79.6% female). At 6 months post-surgery, significant improvements were seen in SPPB (+4.35) and HGS (+1.36 kg), with notable gains among frail patients. MPI scores declined (-0.15), and Walking Test improved (+1.92). MPI showed the strongest predictive power (AUC 0.89). Higher MPI (HR 3.47) and lower HGS (HR 0.88) were significantly associated with mortality. Male sex also increased mortality risk (HR 5.99). MPI and HGS effectively predicted adverse outcomes over 6 months, supporting their use in risk stratification for older adults’ post-surgery for fractures or total knee arthroplasty surgery.
- 26 August 2025
- Published by PAGEPress Publications in European Journal of Translational Myology
- Vol. 35 (3)
Open AccessObservational study for multidimensional assessment in elderly patients hospitalized for post-fracture or elective surgery and functional rehabilitation
Fracture-related hospitalizations are frequent in older adults, with recovery often extended. This study evaluated the prognostic utility of the Multidimensional Prognostic Index (MPI), Handgrip Strength (HGS), Short Physical Performance Battery (SPPB), and Geriatric Depression Scale (GDS) in predicting adverse outcomes—hospitalizations, falls, or mortality—after femoral fracture or total knee arthroplasty surgery. The methods adopted were MPI assessed frailty, SPPB measured physical performance, GDS identified depression, and HGS evaluated muscle strength. Receiver Operating Characteristic (ROC) curves determined their predictive value for adverse outcomes. The study included 206 older adults (mean age 77.5, 79.6% female). At 6 months post-surgery, significant improvements were seen in SPPB (+4.35) and HGS (+1.36 kg), with notable gains among frail patients. MPI scores declined (-0.15), and Walking Test improved (+1.92). MPI showed the strongest predictive power (AUC 0.89). Higher MPI (HR 3.47) and lower HGS (HR 0.88) were significantly associated with mortality. Male sex also increased mortality risk (HR 5.99). MPI and HGS effectively predicted adverse outcomes over 6 months, supporting their use in risk stratification for older adults’ post-surgery for fractures or total knee arthroplasty surgery.
- Open Access
- 28 July 2025
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 37 (1) , 236
Weight of time: exploring the link between obesity and aging
Obesity and aging are interrelated public health concerns, with growing prevalence, especially as global demographics shift toward an older population. This narrative review explores the mechanisms through which obesity accelerates the aging process, focusing on major aging pathways affected by obesity, including deregulated nutrient sensing, telomeres attrition, epigenetic alterations, mitochondrial dysfunction, stem cell exhaustion, and altered intercellular communication. Evidence suggests that these disruptions not only drive age-related diseases, such as cardiovascular disease, type 2 diabetes, and neurodegenerative conditions, but also exacerbate mobility limitations, cognitive decline, and reduced quality of life in older adults. The role of lifestyle interventions, particularly adherence to the Mediterranean diet, is emphasized for its anti-inflammatory and metabolic benefits, alongside strategies to address the social and psychological impacts of obesity on aging. By recognizing obesity as a significant modifiable risk factor for accelerated aging, this review advocates comprehensive and targeted interventions to promote healthier aging and improve quality of life in older populations globally.
- 28 July 2025
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 37 (1) , 236
Open AccessWeight of time: exploring the link between obesity and aging
Obesity and aging are interrelated public health concerns, with growing prevalence, especially as global demographics shift toward an older population. This narrative review explores the mechanisms through which obesity accelerates the aging process, focusing on major aging pathways affected by obesity, including deregulated nutrient sensing, telomeres attrition, epigenetic alterations, mitochondrial dysfunction, stem cell exhaustion, and altered intercellular communication. Evidence suggests that these disruptions not only drive age-related diseases, such as cardiovascular disease, type 2 diabetes, and neurodegenerative conditions, but also exacerbate mobility limitations, cognitive decline, and reduced quality of life in older adults. The role of lifestyle interventions, particularly adherence to the Mediterranean diet, is emphasized for its anti-inflammatory and metabolic benefits, alongside strategies to address the social and psychological impacts of obesity on aging. By recognizing obesity as a significant modifiable risk factor for accelerated aging, this review advocates comprehensive and targeted interventions to promote healthier aging and improve quality of life in older populations globally.
- Top Cited PapersOpen Access
Associations Between Adherence to the Mediterranean Diet and Incident Sarcopenia in Prospective Cohort Studies
The loss of skeletal muscle mass and strength, known as sarcopenia, is prevalent in older adults and linked to an increased risk of disability, frailty, and early mortality. Muscle health is crucial for the functionality and independence of older adults. As the aging population continuously grows, finding cost-effective strategies for preventing and treating sarcopenia is an important public health priority. While nutrition is recognized as a key factor in the development of sarcopenia, its role in preventing and treating the condition is still under investigation. In recent decades, nutritional research has shifted from a focus on individual nutrients or healthy foods to examining the combination of nutrients and foods in dietary patterns, along with their potential synergistic and antagonistic effects. A balanced diet and regular participation in physical activity are essential for maintaining musculoskeletal health. One of the healthy eating patterns with the greatest evidence of multiple health benefits is the Mediterranean diet, which has also been linked to positive effects on muscle function in observational studies. However, there is a lack of intervention studies. This review explores the updated evidence from longitudinal prospective studies on associations between adherence to the Mediterranean diet and sarcopenia in order to promote preventive and intervention strategies for healthy muscle aging.
Top Cited PapersOpen AccessAssociations Between Adherence to the Mediterranean Diet and Incident Sarcopenia in Prospective Cohort Studies
The loss of skeletal muscle mass and strength, known as sarcopenia, is prevalent in older adults and linked to an increased risk of disability, frailty, and early mortality. Muscle health is crucial for the functionality and independence of older adults. As the aging population continuously grows, finding cost-effective strategies for preventing and treating sarcopenia is an important public health priority. While nutrition is recognized as a key factor in the development of sarcopenia, its role in preventing and treating the condition is still under investigation. In recent decades, nutritional research has shifted from a focus on individual nutrients or healthy foods to examining the combination of nutrients and foods in dietary patterns, along with their potential synergistic and antagonistic effects. A balanced diet and regular participation in physical activity are essential for maintaining musculoskeletal health. One of the healthy eating patterns with the greatest evidence of multiple health benefits is the Mediterranean diet, which has also been linked to positive effects on muscle function in observational studies. However, there is a lack of intervention studies. This review explores the updated evidence from longitudinal prospective studies on associations between adherence to the Mediterranean diet and sarcopenia in order to promote preventive and intervention strategies for healthy muscle aging.